Letter to the editor: COVID-19 vaccination uptake among pregnant individuals.

[Linked article: This correspondence comments on the Brief Communication from Rodriguez‐Sibaja et al.: https://doi.org/10.1002/ijgo.14344].

We would like to share ideas on the publication “COVID‐19 vaccination uptake among pregnant individuals in a middle‐income setting”. Rodriguez‐Sibaja et al. discuss the problem of vaccination uptake among pregnant people. Everyone can agree that the association between the COVID‐19 vaccine and vaccination reluctance is a severe problem that, if left unattended, may spread to other conventional vaccines and medical procedures. However, we should bear in mind that a number of factors, such as the location and intensity of the epidemic, may impact a person's decision to take the COVID‐19 vaccination. Local attitudes toward public health systems during the COVID‐19 pandemic have been influenced by levels of trust in those health systems. Adoption rates may shift dramatically when additional information about the effectiveness and safety of vaccines becomes available. According to a Chinese study, acceptance preferences change with time. A new longitudinal study paradigm should be employed to assess the effects of COVID‐19 and COVID‐19 immunization. To assess the effects of COVID‐19 and COVID‐19 vaccine‐linked variables, an additional longitudinal study model should be used rather than the conventional cross‐sectional approach. The outcomes of such a prospective study can be used to improve immunization methods and update existing information.